Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 3, 2011, Pages 531-538

  Lehto, Paula ^a,b   Kortejärvi, Hanna ^b   Liimatainen, Anni ^b   Ojala, Krista ^b   Kangas, Heli ^b   Hirvonen, Jouni ^a   Tanninen, Veli Pekka ^b   Peltonen, Leena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

Biorelevant media; Compartmental absorption and transit (CAT) model; Dissolution; Fasted state simulated intestinal fluid (FaSSIF); In vitro in vivo correlation (IVIVC); Pharmacokinetic simulation

Indexed keywords

ANIONIC SURFACTANT; DANAZOL; NONIONIC SURFACTANT; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SPIRONOLACTONE; SURFACTANT; TAUROCHOLIC ACID;

AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG SOLUBILITY; FASTED STATE SIMULATED INTESTINAL FLUID; HYDROPHOBICITY; IN VIVO STUDY; INTESTINE FLUID; MAXIMUM PLASMA CONCENTRATION; MICELLE; PHYSIOLOGY; PREDICTION; QUALITY CONTROL; SIMULATION; SURFACE TENSION;

ABSORPTION; ANIMALS; BIOPHARMACEUTICS; BODY FLUIDS; COMPUTER SIMULATION; DANAZOL; DIURETICS; DOGS; ESTROGEN ANTAGONISTS; FASTING; FEMALE; INTESTINES; MALE; MICELLES; PHARMACEUTICAL PREPARATIONS; POLYSORBATES; SODIUM DODECYL SULFATE; SOLUBILITY; SPIRONOLACTONE; SURFACE-ACTIVE AGENTS;

EID: 79960592269     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.02.007     Document Type: Article

References (33)

1. S. Stegman, F. Leveiller, D. Franchi, H. de Jong, and H. Linden When poor solubility becomes an issue: from early stage to proof of concept Eur. J. Pharm. Sci. 31 2007 249 261 (Pubitemid 47079001)
2. G.L. Amidon, H. Lennernäs, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
3. J.H. Porter, and W.N. Charman In vitro assessment of oral lipid based formulations Adv. Drug Deliv. Rev. 50 2001 127 147
4. USP XXXI, <711> Dissolution and Monographs. The United States Pharmacopeial Convention, Rockville, 2008.
5. E. Galia, E. Nicolaides, D. Hörter, R. Löbenberg, C. Reppas, and J.B. Dressman Evaluation of various dissolution media for predicting in vivo performance of class I and class II drugs Pharm. Res. 15 1998 698 705 (Pubitemid 28275645)
6. E. Nicolaides, M. Symillides, J.B. Dressman, and C. Reppas Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration Pharm. Res. 18 2001 380 388 (Pubitemid 32595828)
7. V.H. Sunesen, B.L. Pedersen, H.G. Kristensen, and A. Müllertz In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow through dissolution method with biorelevant dissolution media Eur. J. Pharm. Sci. 24 2005 305 313 (Pubitemid 40283513)
8. H. Wei, and R. Löbenberg Biorelevant dissolution media as a predictive tool for glyburide a class II drug Eur. J. Pharm. Sci. 29 2006 45 52 (Pubitemid 44279396)
9. B.-M. Lue, F.S. Nielsen, T. Magnussen, H.M. Schou, K. Kristensen, L.O. Jacobseb, and A. Müllertz Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly soluble model compound Eur. J. Pharm. Biopharm. 69 2008 648 657
10. E. Jantratid, N. Janssen, H. Chokshi, K. Tang, and J.B. Dressman Designing biorelevant dissolution tests for lipid formulations: case example - lipid suspension of RZ-50 Eur. J. Pharm. Biopharm. 69 2008 776 785
11. T.S. Wiedman, W. Liang, and L. Kamel Solubilization of drugs by physiological mixtures of bile salts Pharm. Res. 19 2002 1203 1208 (Pubitemid 34985005)
12. Center for Drug Evaluation and Research (CDER), FDA Guidance for Industry; Dissolution Testing of Immediate Release Solid Oral Dosage Forms, Rockville, 1997.
13. L.X. Yu, J.R. Crison, and G.L. Amidon Compartmental transit and dispersion model analysis of small intestinal transit flow in humans Int. J. Pharm. 140 1996 111 118 (Pubitemid 26276720)
14. E. Galia, J. Horton, and J.B. Dressman Albendazole generics - a comparative in vitro study Pharm. Res. 16 1999 1871 1875 (Pubitemid 30040704)
15. M. Marques Dissolution media simulating fasted and fed states Dissolution Tech. 4 2004 14
16. B.L. Pedersen, H. Bronsted, H. Lennernäs, F.N. Kristensen, A. Müllertz, and H.G. Kristensen Dissolution of hydrocortisone in human and simulated intestinal fluids Pharm. Res. 17 2000 183 189 (Pubitemid 30158367)
17. H. Kortejärvi, A. Urtti, and M. Yliperttula Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates Eur. J. Pharm. Sci. 30 2007 155 166 (Pubitemid 46157177)
18. J.B. Dressman, and K. Yamada P. Welling, F.L. Tse, Animal Models for Oral Drug Absorption Pharmaceutical Bioequivalence 1991 Dekker New York 256
19. J.D.R. Schulze, E.E. Peters, A.W. Vickers, J.S. Staton, M.D. Coffin, G.E. Parsons, and A.W. Basit Excipients effects on gastrointestinal transit and drug absorption in beagle dogs Int. J. Pharm. 300 2005 67 75 (Pubitemid 41112168)
20. A.C. Andersson A.C. Andersson, L.S. Good, Digestive System in Beagle Dogs as Experimental Animal 1970 Iowa State University Press Ames, IA 226 231
21. P. Lánský, and P. Weiss P Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity J. Pharm. Sci. 8 2003 1632 1647 (Pubitemid 36929683)
22. C.S. Khan, and C.T. Rhodes The concept of dissolution efficiency J. Pharm. Pharmacol. 27 1975 48 49
23. L.J. Naylor, V. Bakatselou, and J.B. Dressman Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems Pharm. Res. 10 1993 865 870 (Pubitemid 23167569)
24. K. Matsuoka, M. Maeda, and Y. Moroi Micelle formation of sodium glycol-and taurocholates and solubilization of cholesterol into their micelles Colloids Surf. B: Biointerfaces 32 2003 87 95 (Pubitemid 37083515)
25. S.H. Yalkowsky S.H. Yalkowsky, Solubility and Solubilization in Aqueous Media 1999 Oxford University Press New York 262 266
26. G.A. Kossena, B.J. Boyd, C.J. Porter, and W.N. Charman Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs J. Pharm. Sci. 92 2003 634 648 (Pubitemid 36258978)
27. D. Ilardia-Arana, H.G. Kristensen, and A. Müllertz Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol J. Pharm. Sci. 2 2005 248 2006
28. E. Nicolaides, J.M. Hempenstall, and C. Reppas Biorelevant dissolution tests with the flow-through apparatus? Dissolution Tech. 7 2000 8 15
29. USP-NF (Pharmacopeial Forum), The dissolution procedure: development and validation (1092), in process revision, The United States Pharmacopeial Convention, Rockville, vol. 31, 2005, pp. 1463-1475.
30. R.L. Dillard, H. Eastman, and J.S. Fodtran Volume-flow relationship during the transport of fluid through the human small intestine Gastroenterology 49 1965 58 66
31. J.B. Dressman, G.L. Amidon, C. Reppas, and V.P. Shah Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms Pharm. Res. 15 1998 11 22 (Pubitemid 28080861)
32. J.B. Dressman Comparison of canine and human gastrointestinal physiology Pharm. Res. 3 1986 23 131
33. A.S. Carlsson, E.S. Kostewicz, G. Hanisch, K. Krumkuhler, R.G. Nilsson, L. Loefgren, B. Abrahamsson, Is the dog a suitable model for bioavailability studies of poorly soluble drugs? In: Congress abstract in AAPS Annual Meeting and Exposition. Springer, Berlin, 2002.